Stock EDIT EDITAS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
4.67 USD -1.48% Intraday chart for Editas Medicine, Inc. -8.61% -53.90%
06-14 Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial MT
06-14 Editas Medicine, Inc. Reports New Safety and Efficacy Data from the Rubber Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association Annual Congress CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EDITAS MEDICINE, INC.
Other Biotechnology & Medical Research
-1.48%-8.61%-53.90%-44.40%-81.12% 384M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. EDIT Stock
  4. Charts Editas Medicine, Inc.
  5. Comparison Chart